Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptive Biotechnologies Corp shares valued at $1,235 were sold by PISKEL KYLE on Nov 18 ’24. At $4.98 per share, PISKEL KYLE sold 248 shares. The insider’s holdings dropped to 154,330 shares worth approximately $0.95 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Taylor Stacy L sold 26,922 shares, netting a total of over 121,079 in proceeds. Following the sale of shares at $4.50 each, the insider now holds 139,365 shares.
Before that, STACY L TAYLOR had added 26,922 shares to its account. In a trade valued at $121,079, the Officer bought Adaptive Biotechnologies Corp shares for $4.50 each.
Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early January. As of December 21, 2022, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for ADPT. Earlier on August 25, 2022, Credit Suisse initiated its rating. Their recommendation was “an Underperform” for ADPT stock.
Analyzing ADPT Stock Performance
During the last five days, there has been a surge of approximately 8.10%. Over the course of the year, Adaptive Biotechnologies Corp shares have jumped approximately 25.31%. Shares of the company reached a 52-week high of $6.70 on 11/11/24 and a 52-week low of $2.28 on 04/19/24. A 50-day SMA is recorded $5.17, while a 200-day SMA reached $4.07. Nevertheless, trading volume fell to 1.14 million shares from 4.01 million shares the previous day.
Support And Resistance Levels for Adaptive Biotechnologies Corp (ADPT)
According to the 24-hour chart, there is a support level at 6.01, which, if violated, would cause prices to drop to 5.87. In the upper region, resistance lies at 6.36. The next price resistance is at 6.58. RSI (Relative Strength Index) is 60.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.95, which suggests the price will decrease in the coming days. Percent R is at 18.87%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
